# Universitätsklinikum Erlangen

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/universitatsklinikum-erlangen/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 74.9 |
| Citations | 2,648,576 |
| City | Erlangen |
| Country | DE |
| Description | Universitätsklinikum Erlangen is a research organisation in Erlangen, DE. OpenAlex records 35,293 works and 2,648,576 citations for it. 9,138 researchers list it as their most recent affiliation. |
| Homepage | http://www.uk-erlangen.de/en/ |
| OpenAlex ID | https://openalex.org/I4210088053 |
| Researchers | 9,138 |
| ROR ID | https://ror.org/0030f2a11 |
| Type | healthcare |
| Works | 35,293 |

## University papers

Showing 12 of 47.

- [2007 Guidelines for the Management of Arterial Hypertension](https://scholariq.org/papers/2007-guidelines-for-the-management-of-arterial-hypertension/)
- [2013 ESH/ESC Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2013-esh-esc-guidelines-for-the-management-of-arterial-hypertension-2/)
- [Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis](https://scholariq.org/papers/pathological-complete-response-and-long-term-clinical-benefit-in-breast-cancer/)
- [Pembrolizumab for Early Triple-Negative Breast Cancer](https://scholariq.org/papers/pembrolizumab-for-early-triple-negative-breast-cancer/)
- [2018 ESC/ESH Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2018-esc-esh-guidelines-for-the-management-of-arterial-hypertension-2/)
- [Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes](https://scholariq.org/papers/definition-and-impact-of-pathologic-complete-response-on-prognosis-after/)
- [Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-emtansine-for-residual-invasive-her2-positive-breast-cancer/)
- [Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy](https://scholariq.org/papers/tumour-infiltrating-lymphocytes-and-prognosis-in-different-subtypes-of-breast/)
- [Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis](https://scholariq.org/papers/rosuvastatin-and-cardiovascular-events-in-patients-undergoing-hemodialysis/)
- [2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension](https://scholariq.org/papers/2007-esh-esc-practice-guidelines-for-the-management-of-arterial-hypertension/)
- [Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document](https://scholariq.org/papers/reappraisal-of-european-guidelines-on-hypertension-management-a-european-society-2/)
- [Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial](https://scholariq.org/papers/renal-outcomes-with-telmisartan-ramipril-or-both-in-people-at-high-vascular-risk/)

## University researchers

- [Roland E. Schmieder](https://scholariq.org/researchers/roland-e-schmieder/)
- [Marcel Betsch](https://scholariq.org/researchers/marcel-betsch/)

## University top topics

Showing 8 of 24.

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Advanced MRI Techniques and Applications](https://scholariq.org/topics/advanced-mri-techniques-and-applications/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.